Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine

With the emergence of immune checkpoint inhibitors and adoptive T-cell therapies, there is a considerable interest in using personalized autologous dendritic cell (DC) vaccines in combination with T cell-targeting immunotherapies to potentially maximize the therapeutic impact of DC vaccines. Here, w...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Caroline Boudousquié, Valérie Boand, Emilie Lingre, Laeticia Dutoit, Klara Balint, Maxime Danilo, Alexandre Harari, Philippe O. Gannon, Lana E. Kandalaft
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	MDPI AG 2020-01-01
श्रृंखला:	Vaccines
विषय:	immunotherapy dendritic cell vaccine manufacturing gmp tumor lysate
ऑनलाइन पहुंच:	https://www.mdpi.com/2076-393X/8/1/25
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!